Long-term outcomes of vitrectomy for proliferative diabetic retinopathy: a real world study in China.

IF 1.4 4区 医学 Q3 OPHTHALMOLOGY
Jinghao Mei, Hantao Zhou, Chuying Deng, Shimeng Wang, Binghua Guo, Wei Lin, Zushun Lin, Ke Lin, Ronghan Wu, Zhong Lin
{"title":"Long-term outcomes of vitrectomy for proliferative diabetic retinopathy: a real world study in China.","authors":"Jinghao Mei, Hantao Zhou, Chuying Deng, Shimeng Wang, Binghua Guo, Wei Lin, Zushun Lin, Ke Lin, Ronghan Wu, Zhong Lin","doi":"10.1007/s10792-025-03722-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate long-term outcomes and their predictive factors in Chinese patients with proliferative diabetic retinopathy (PDR) after vitrectomy.</p><p><strong>Study design: </strong>Retrospective and observational.</p><p><strong>Methods: </strong>PDR patients who underwent vitrectomy in a tertiary eye hospital from 2010 to 2020 were enrolled. The cumulative incidences of re-vitrectomy in the primary eye, vitrectomy in the contralateral eye, low vision (< 0.3 Snellen), and postoperative complications were calculated.</p><p><strong>Results: </strong>A total of 1094 patients were included in the analysis. The 1-, 3-, and 5-year cumulative incidences for low vision in both eyes were 18.9%, 34.7%, and 44.4%, respectively. The 1-, 5-, and 10-year cumulative incidences for re-vitrectomy in the primary eye were 7.4%, 9.9%, and 9.9%, respectively, and for vitrectomy in the contralateral eye were 31.0%, 62.7%, and 79.5%, respectively. Vitrectomy in the contralateral eye was associated with younger age (hazard ratio [HR] = 0.99, 95% confidence interval [CI] 0.98-0.99), higher glycated hemoglobin (HR = 1.17, 95% CI 1.08-1.27), no preoperative photocoagulation (HR = 0.55, 95% CI 0.39-0.78), severer diabetic retinopathy level (HR = 2.28, 95% CI 1.56-3.33), and poorer preoperative vision (HR = 1.35, 95% CI 1.14-1.61). The cumulative postoperative incidences of the primary eye at 1, 5, and 10 years were 5.7%, 9.9%, and 9.9% for vitreous hemorrhage, 4.2%, 5.1%, and 5.1% for retinal detachment, and 2.8%, 6.2%, and 8.1% for neovascular glaucoma, respectively.</p><p><strong>Conclusion: </strong>This study reported a comprehensive post-vitrectomy incidence and predictive factors in Chinese PDR patients in a long-term follow up. This would aid in the clinical understanding of this lifelong disease.</p>","PeriodicalId":14473,"journal":{"name":"International Ophthalmology","volume":"45 1","pages":"366"},"PeriodicalIF":1.4000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10792-025-03722-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To investigate long-term outcomes and their predictive factors in Chinese patients with proliferative diabetic retinopathy (PDR) after vitrectomy.

Study design: Retrospective and observational.

Methods: PDR patients who underwent vitrectomy in a tertiary eye hospital from 2010 to 2020 were enrolled. The cumulative incidences of re-vitrectomy in the primary eye, vitrectomy in the contralateral eye, low vision (< 0.3 Snellen), and postoperative complications were calculated.

Results: A total of 1094 patients were included in the analysis. The 1-, 3-, and 5-year cumulative incidences for low vision in both eyes were 18.9%, 34.7%, and 44.4%, respectively. The 1-, 5-, and 10-year cumulative incidences for re-vitrectomy in the primary eye were 7.4%, 9.9%, and 9.9%, respectively, and for vitrectomy in the contralateral eye were 31.0%, 62.7%, and 79.5%, respectively. Vitrectomy in the contralateral eye was associated with younger age (hazard ratio [HR] = 0.99, 95% confidence interval [CI] 0.98-0.99), higher glycated hemoglobin (HR = 1.17, 95% CI 1.08-1.27), no preoperative photocoagulation (HR = 0.55, 95% CI 0.39-0.78), severer diabetic retinopathy level (HR = 2.28, 95% CI 1.56-3.33), and poorer preoperative vision (HR = 1.35, 95% CI 1.14-1.61). The cumulative postoperative incidences of the primary eye at 1, 5, and 10 years were 5.7%, 9.9%, and 9.9% for vitreous hemorrhage, 4.2%, 5.1%, and 5.1% for retinal detachment, and 2.8%, 6.2%, and 8.1% for neovascular glaucoma, respectively.

Conclusion: This study reported a comprehensive post-vitrectomy incidence and predictive factors in Chinese PDR patients in a long-term follow up. This would aid in the clinical understanding of this lifelong disease.

玻璃体切除术治疗增殖性糖尿病视网膜病变的长期疗效:中国的一项真实世界研究。
目的:探讨中国玻璃体切除术后增殖性糖尿病视网膜病变(PDR)患者的远期预后及其预测因素。研究设计:回顾性观察。方法:选取2010 ~ 2020年在某三级眼科医院行玻璃体切除术的PDR患者。原眼再玻璃体切除术、对侧眼玻璃体切除术、低视力的累计发生率(结果:共纳入1094例患者。双眼低视力1、3、5年累计发生率分别为18.9%、34.7%、44.4%。原眼再次玻璃体切除术的1年、5年和10年累积发病率分别为7.4%、9.9%和9.9%,对侧眼玻璃体切除术的累积发病率分别为31.0%、62.7%和79.5%。对侧眼玻璃体切除术与年龄较轻(风险比[HR] = 0.99, 95%可信区间[CI] 0.98-0.99)、糖化血红蛋白较高(HR = 1.17, 95% CI 1.08-1.27)、术前无光凝(HR = 0.55, 95% CI 0.39-0.78)、糖尿病视网膜病变程度较重(HR = 2.28, 95% CI 1.56-3.33)、术前视力较差(HR = 1.35, 95% CI 1.14-1.61)相关。术后1年、5年和10年原眼的累计发生率,玻璃体出血分别为5.7%、9.9%和9.9%,视网膜脱离为4.2%、5.1%和5.1%,新生血管性青光眼分别为2.8%、6.2%和8.1%。结论:本研究通过长期随访全面报道了中国PDR患者玻璃体切除术后的发病率及预测因素。这将有助于临床理解这种终身疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
0.00%
发文量
451
期刊介绍: International Ophthalmology provides the clinician with articles on all the relevant subspecialties of ophthalmology, with a broad international scope. The emphasis is on presentation of the latest clinical research in the field. In addition, the journal includes regular sections devoted to new developments in technologies, products, and techniques.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信